Biomedical Ίδρυμα Ιατροβιολογικών Ερευνών, Ακαδημίας ΑθηνώνΑκαδημία Αθηνών
Επιστημονικό Προσωπικό

Κωνσταντίνος Κωνσταντίνος Ταμβακόπουλος, PhD
Ερευνητής Α'

Τηλέφωνο : +30 210 6597475
e-mail :

Κέντρο :

Κλινική, Πειραματική Χειρουργική & Μεταφραστική Έρευνα

Ιστοσελίδα Εργαστηρίου :

Εργαστήριο Ταμβακόπουλου

Επιλεγμένες Δημοσιεύσεις

Kanaki, Z., Smina, A., Chandrinou, C., Koukouzeli, F. E., Ntounias, Y., Paschalidis, N., ... & Klinakis, A. (2023). Printed cisplatin on microneedle arrays for transdermal delivery enhances olaparib-induced synthetic lethality in a mouse model of homologous recombination deficiency. International Journal of Bioprinting, 9(6), 0048.

Chatzisideri, T., Leonidis, G., Karampelas, T., Skavatsou, E., Velentza-Almpani, A., Bianchini, F., ... & Sarli, V. (2022). Integrin-Mediated Targeted Cancer Therapy Using c (RGDyK)-Based Conjugates of Gemcitabine. Journal of Medicinal Chemistry, 65(1), 271-284.

Orfanou, I. M., Argyros, O., Papapetropoulos, A., Tseleni-Balafouta, S., Vougas, K., & Tamvakopoulos, C. (2021). Discovery and pharmacological evaluation of STEAP4 as a novel target for HER2 overexpressing breast cancer. Frontiers in Oncology, 11, 608201.

Skavatsou, E., Semitekolou, M., Morianos, I., Karampelas, T., Lougiakis, N., Xanthou, G., & Tamvakopoulos, C. (2021). Immunotherapy combined with metronomic dosing: An effective approach for the treatment of nsclc. Cancers, 13(8), 1901.

Vrettos, E. I., Karampelas, T., Sayyad, N., Kougioumtzi, A., Syed, N., Crook, T., ... & Tzakos, A. G. (2021). Development of programmable gemcitabine-GnRH pro-drugs bearing linker controllable “click” oxime bond tethers and preclinical evaluation against prostate cancer. European Journal of Medicinal Chemistry, 211, 113018.

Soulele, K., Karampelas, T., Tamvakopoulos, C., & Macheras, P. (2021). Enhancement of Docetaxel Absorption Using Ritonavir in an Oral Milk-Based Formulation. Pharmaceutical Research, 38(8), 1419-1428.

Pyrillou, K., Chairakaki, A. D., Tamvakopoulos, C., & Andreakos, E. (2018). Dexamethasone induces ω3-derived immunoresolvents driving resolution of allergic airway inflammation. Journal of allergy and clinical immunology, 142(2), 691-695.

Argyros, O., Karampelas, T., Asvos, X., Varela, A., Sayyad, N., Papakyriakou, A., ... & Tamvakopoulos, C. (2016). Peptide–Drug Conjugate GnRH–Sunitinib Targets Angiogenesis Selectively at the Site of Action to Inhibit Tumor Growth. Cancer Research, 76(5), 1181-1192.

Stellas, D., Szabolcs, M., Koul, S., Li, Z., Polyzos, A., Anagnostopoulos, C., ... & Efstratiadis, A. (2014). Therapeutic effects of an anti-Myc drug on mouse pancreatic cancer. Journal of the National Cancer Institute, 106(12), dju320.

Katsila, T., Siskos, A. P., & Tamvakopoulos, C. (2012). Peptide and protein drugs: the study of their metabolism and catabolism by mass spectrometry. Mass spectrometry reviews, 31(1), 110-133.

Zhu, L., Tamvakopoulos, C., Xie, D., Dragovic, J., Shen, X., Fenyk-Melody, J. E., ... & Roy, R. S. (2003). The role of dipeptidyl peptidase IV in the cleavage of glucagon family peptides: in vivo metabolism of pituitary adenylate cyclase-activating polypeptide-(1–38). Journal of Biological Chemistry, 278(25), 22418-22423.

Van der Ploeg, L. H., Martin, W. J., Howard, A. D., Nargund, R. P., Austin, C. P., Guan, X., ... & MacIntyre, D. E. (2002). A role for the melanocortin 4 receptor in sexual function. Proceedings of the National Academy of Sciences, 99(17), 11381-11386.


PubMed Link